These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 38442780)
1. Immunotherapy for depression: Recent insights and future targets. Bai Y; Cai Y; Chang D; Li D; Huo X; Zhu T Pharmacol Ther; 2024 May; 257():108624. PubMed ID: 38442780 [TBL] [Abstract][Full Text] [Related]
3. Immune targets for therapeutic development in depression: towards precision medicine. Drevets WC; Wittenberg GM; Bullmore ET; Manji HK Nat Rev Drug Discov; 2022 Mar; 21(3):224-244. PubMed ID: 35039676 [TBL] [Abstract][Full Text] [Related]
4. Cytokines: abnormalities in major depression and implications for pharmacological treatment. O'Brien SM; Scott LV; Dinan TG Hum Psychopharmacol; 2004 Aug; 19(6):397-403. PubMed ID: 15303243 [TBL] [Abstract][Full Text] [Related]
5. Neuro-immune crosstalk in depressive symptoms of multiple sclerosis. Wang C; Zhou Y; Feinstein A Neurobiol Dis; 2023 Feb; 177():106005. PubMed ID: 36680805 [TBL] [Abstract][Full Text] [Related]
6. Antidepressant Effect of Ketamine on Inflammation-Mediated Cytokine Dysregulation in Adults with Treatment-Resistant Depression: Rapid Systematic Review. Sukhram SD; Yilmaz G; Gu J Oxid Med Cell Longev; 2022; 2022():1061274. PubMed ID: 36160713 [TBL] [Abstract][Full Text] [Related]
7. Nrf2 activation rescues stress-induced depression-like behaviour and inflammatory responses in male but not female rats. McCallum RT; Thériault RK; Manduca JD; Russell ISB; Culmer AM; Doost JS; Martino TA; Perreault ML Biol Sex Differ; 2024 Feb; 15(1):16. PubMed ID: 38350966 [TBL] [Abstract][Full Text] [Related]
8. Side effect profile similarities shared between antidepressants and immune-modulators reveal potential novel targets for treating major depressive disorders. Sun Y; Narayan VA; Wittenberg GM BMC Pharmacol Toxicol; 2016 Oct; 17(1):47. PubMed ID: 27765060 [TBL] [Abstract][Full Text] [Related]
9. [Brain-immune interactions and implications in psychiatric disorders]. Marques AH; Cizza G; Sternberg E Braz J Psychiatry; 2007 May; 29 Suppl 1():S27-32. PubMed ID: 17546344 [TBL] [Abstract][Full Text] [Related]
10. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants]. Leblé N; Radon L; Rabot M; Godart N Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149 [TBL] [Abstract][Full Text] [Related]
11. Microglia in depression: current perspectives. Jia X; Gao Z; Hu H Sci China Life Sci; 2021 Jun; 64(6):911-925. PubMed ID: 33068286 [TBL] [Abstract][Full Text] [Related]
13. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. Akiskal HS; Benazzi F; Perugi G; Rihmer Z J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694 [TBL] [Abstract][Full Text] [Related]
14. Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. Pollak Y; Yirmiya R Int J Neuropsychopharmacol; 2002 Dec; 5(4):389-99. PubMed ID: 12466037 [TBL] [Abstract][Full Text] [Related]
15. Vaccination and Immunotherapy for Major Depression. Evrensel A; Ünsalver BÖ; Ceylan ME; Tarhan N Adv Exp Med Biol; 2021; 1305():503-513. PubMed ID: 33834415 [TBL] [Abstract][Full Text] [Related]
16. Antidepressants for the treatment of depression in people with cancer. Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474 [TBL] [Abstract][Full Text] [Related]
17. The role of zinc in neurodegenerative inflammatory pathways in depression. Szewczyk B; Kubera M; Nowak G Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):693-701. PubMed ID: 20156515 [TBL] [Abstract][Full Text] [Related]
18. Ketamine: Mechanisms and Relevance to Treatment of Depression. Kim JW; Suzuki K; Kavalali ET; Monteggia LM Annu Rev Med; 2024 Jan; 75():129-143. PubMed ID: 37729028 [TBL] [Abstract][Full Text] [Related]
19. Remission as the critical outcome of depression treatment. Thase ME; Sloan DM; Kornstein SG Psychopharmacol Bull; 2002; 36(4):12-25. PubMed ID: 12858138 [TBL] [Abstract][Full Text] [Related]
20. The efficacy of anti-inflammatory treatment interventions on depression in individuals with major depressive disorder and high levels of inflammation: A systematic review of randomized clinical trials. Allison DJ; Sharma B; Timmons BW Physiol Behav; 2019 Aug; 207():104-112. PubMed ID: 31078670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]